Chinese Medical Journal最新文献

筛选
英文 中文
Evidence and controversies of inositol in women's reproductive health. 肌醇在女性生殖健康中的证据与争议。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-13 DOI: 10.1097/CM9.0000000000004319
Anna A Druzhinina, Safiya M Giulakhmedova, Olga S Alyautdina, Ekaterina M Eliseeva, Anna A Chistokhina
{"title":"Evidence and controversies of inositol in women's reproductive health.","authors":"Anna A Druzhinina, Safiya M Giulakhmedova, Olga S Alyautdina, Ekaterina M Eliseeva, Anna A Chistokhina","doi":"10.1097/CM9.0000000000004319","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004319","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic obstructive pulmonary disease increases the risk of cardiovascular disease occurrence in nonsmokers: A nationwide cohort study. 慢性阻塞性肺疾病增加非吸烟者心血管疾病发生的风险:一项全国性队列研究
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-12 DOI: 10.1097/CM9.0000000000004301
Zhihan Jiang, Qiqiang Zhou, Yingying Dai, Jing Chang, Nan Li, Jun Lv, Yahong Chen, Ying Liang, Yongchang Sun
{"title":"Chronic obstructive pulmonary disease increases the risk of cardiovascular disease occurrence in nonsmokers: A nationwide cohort study.","authors":"Zhihan Jiang, Qiqiang Zhou, Yingying Dai, Jing Chang, Nan Li, Jun Lv, Yahong Chen, Ying Liang, Yongchang Sun","doi":"10.1097/CM9.0000000000004301","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004301","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is among the leading causes of mortality worldwide, and patients experience a high prevalence of concomitant cardiovascular diseases (CVDs). In this study, we aimed to determine whether never smokers with COPD exhibit an increased risk of CVD compared with those without COPD and whether this risk parallels that observed in smokers with COPD.</p><p><strong>Methods: </strong>We conducted a prospective cohort study using data from the China Kadoorie Biobank (CKB). Spirometry was performed on all the participants, and COPD was defined as the ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) <0.7. Eligible participants in our study were free of diagnosed CVDs, including ischemic heart disease, heart failure, hypertension, or atrial fibrillation at baseline. The clinical outcomes were the incidences of these 4 CVDs and their overall incidence during follow-up. Cox proportional hazard models were used to estimate the associations of COPD and smoking status with incident CVD outcomes.</p><p><strong>Results: </strong>Among all eligible participants (n = 366,161, 20,887 with COPD), 40,861 incident cases of CVD events were observed during a median follow-up time of 10 years. Compared with never smokers without COPD, those with COPD exhibited a significantly higher risk of overall CVD, with hazard ratios (HRs) of 1.23 (95% CI: 1.09-1.39) for men and 1.24 (95% CI: 1.17-1.31) for women. Among male COPD participants, the incidence rates of overall CVD, ischemic heart disease, and hypertension, but not that of heart failure, were similar between never smokers and smokers. In contrast, female COPD participants who never smoked exhibited lower risks across all cardiovascular endpoints compared with their smoking counterparts. These results remained unchanged after propensity score matching.</p><p><strong>Conclusion: </strong>In never smokers, COPD per se serves as an independent risk factor for CVD. Among men with COPD, smoking exposure confers no added hazard, whereas women with COPD who smoke remain at higher risk for CVD than their never-smoking counterparts.</p>","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal stem cells in diabetic kidney disease: Potential regulatory mechanisms and related signaling pathways of mesenchymal stem cells. 糖尿病肾病的间充质干细胞:间充质干细胞的潜在调控机制和相关信号通路
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-12 DOI: 10.1097/CM9.0000000000004298
Lunju Luo, Yiyao Deng, Yuqing Sun, Zhengsheng Li, Yongqiang Zhang, Huan Liu, Jie Ding, Zhi Yang, Yan Zha, Jing Yuan
{"title":"Mesenchymal stem cells in diabetic kidney disease: Potential regulatory mechanisms and related signaling pathways of mesenchymal stem cells.","authors":"Lunju Luo, Yiyao Deng, Yuqing Sun, Zhengsheng Li, Yongqiang Zhang, Huan Liu, Jie Ding, Zhi Yang, Yan Zha, Jing Yuan","doi":"10.1097/CM9.0000000000004298","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004298","url":null,"abstract":"<p><strong>Abstract: </strong>Diabetic kidney disease (DKD) is a severe complication of diabetes and the leading cause of end-stage renal disease (ESRD). However, DKD treatment remains challenging owing to its complex etiology and unclear pathogenesis. Recent reports of the anti-inflammatory, antioxidant, antifibrotic, and regenerative properties of mesenchymal stem cells (MSCs) indicate that they may serve as potential novel treatments for kidney disease-particularly DKD. However, current MSC-based therapies for DKD are at the initial clinical stage of research with the precise underlying mechanisms requiring further investigation. Current studies have predominantly concentrated on the renal protective effects mediated by classical signaling pathways such as Wnt/β-catenin, phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR), vascular endothelial growth factor (VEGF), transforming growth factor-β1 (TGF-β1)/Smad, and nuclear factor-erythroid 2-related factor 2 (Nrf2), whereas other potentially relevant pathways remain insufficiently investigated. This review comprehensively discusses the key MSC-regulated signaling pathways and their therapeutic potential to provide a theoretical foundation for DKD-related drug development and its clinical translation.</p>","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Klotho ameliorates renal fibrosis and the regulation of Klotho levels by natural products. Klotho通过天然产物改善肾纤维化和Klotho水平的调节。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-12 DOI: 10.1097/CM9.0000000000004290
Qianqian Zhao, Meihua Jin, Qiang Zhao, Xinyue Zhao, Yujiao Gao, Ran Tao, Donghe Han
{"title":"Klotho ameliorates renal fibrosis and the regulation of Klotho levels by natural products.","authors":"Qianqian Zhao, Meihua Jin, Qiang Zhao, Xinyue Zhao, Yujiao Gao, Ran Tao, Donghe Han","doi":"10.1097/CM9.0000000000004290","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004290","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149165293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ESR1 alterations in breast cancer: Mechanisms, detection, and therapeutic implications. ESR1在乳腺癌中的改变:机制、检测和治疗意义。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-12 DOI: 10.1097/CM9.0000000000004327
Mengjia Shen, Xiaoxia Yao, Xiu Zhao, Yidan Gong, Libo Yang, Mengna Feng, Mengyuan Shao, Bing Wei, Hong Bu, Zhang Zhang
{"title":"ESR1 alterations in breast cancer: Mechanisms, detection, and therapeutic implications.","authors":"Mengjia Shen, Xiaoxia Yao, Xiu Zhao, Yidan Gong, Libo Yang, Mengna Feng, Mengyuan Shao, Bing Wei, Hong Bu, Zhang Zhang","doi":"10.1097/CM9.0000000000004327","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004327","url":null,"abstract":"<p><strong>Abstract: </strong>Endocrine therapy plays a central role in the treatment of hormone receptor-positive (HR+) breast cancer, but acquired resistance remains a major clinical challenge. Increasing evidence suggests that ESR1 alterations are key molecular events that maintain estrogen receptor (ER) signaling and drive endocrine treatment failure. In this review, we summarize the biological basis of ESR1/ERα signaling and place it within the broader context of the nuclear ER family, including the partially opposing role of ESR2/ERβ and its potential influence on the prognostic and predictive value of conventional ER/progesterone receptor (PR) status. We then discuss the main categories of ESR1 alterations in breast cancer, including ligand-binding domain (LBD) mutations, structural rearrangements/fusions, copy-number changes, and splice isoforms. Hotspot mutations such as Y537S and D538G cause ligand-independent receptor activation and are commonly detected after aromatase inhibitor exposure, supporting their central role in acquired endocrine resistance. ESR1 fusions, amplification, and isoform diversity further broaden the complexity of ER signaling through transcriptional reprogramming, bypass pathway activation, and nongenomic signaling. We also review the clinical application of circulating tumor DNA (ctDNA) in dynamic molecular monitoring and summarize current therapeutic advances, including oral selective ER degraders (SERDs), proteolysis-targeting chimera (PROTAC) ER degraders, and mechanism-based combination strategies targeting cyclin-dependent kinases 4/6 (CDK4/6), phosphoinositide 3-kinase (PI3K)-protein kinase B-mammalian target of rapamycin (mTOR), fibroblast growth factor receptor (FGFR), human epidermal growth factor receptor 2, and related pathways. Finally, we propose a stratified treatment framework that integrates alteration type, mutation subtype, ctDNA dynamics, treatment line, and coalterations to guide individualized therapy. Standardized molecular testing, real-time ctDNA surveillance, and next-generation ER-targeted therapies, together with a clearer understanding of the wider ER family, may provide new opportunities for precision treatment of endocrine-resistant breast cancer.</p>","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149165477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of kidney transplantation with kidneys from donors undergoing ischemia-free liver procurement. 供者肾脏接受无缺血肝获取肾移植的结果。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-12 DOI: 10.1097/CM9.0000000000004336
Zehuan Chen, Xutao Chen, Weiqiang Ju, Maogen Chen, Jun Li, Xinhua Chang, Chenglin Wu, Gang Huang, Bowen Xu, Guodong Chen, Jiang Qiu, Qian Fu, Longshan Liu, Huanxi Zhang, Zhiyong Guo, Qiang Zhao, Yinghua Chen, Jiguang Fei, Yi Ma, Changxi Wang, Suxiong Deng, Xiaoshun He, Ronghai Deng
{"title":"Outcomes of kidney transplantation with kidneys from donors undergoing ischemia-free liver procurement.","authors":"Zehuan Chen, Xutao Chen, Weiqiang Ju, Maogen Chen, Jun Li, Xinhua Chang, Chenglin Wu, Gang Huang, Bowen Xu, Guodong Chen, Jiang Qiu, Qian Fu, Longshan Liu, Huanxi Zhang, Zhiyong Guo, Qiang Zhao, Yinghua Chen, Jiguang Fei, Yi Ma, Changxi Wang, Suxiong Deng, Xiaoshun He, Ronghai Deng","doi":"10.1097/CM9.0000000000004336","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004336","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second allogeneic hematopoietic stem cell transplantation treatment for post-transplant relapse in myeloid hematologic malignancies. 异基因造血干细胞移植治疗髓系恶性血液病移植后复发。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-10 DOI: 10.1097/CM9.0000000000004303
Haixiao Zhang, Weijie Cao, Jia Liu, Ping Zhang, Wenwen Guo, Caidong Hu, Bo Nie, Qianwen Hu, Hongye Gao, Zhongxing Jiang, Guifang Ouyang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Mingxia Shi, Ting Yang, Fuxu Wang, Xi Zhang, Erlie Jiang
{"title":"Second allogeneic hematopoietic stem cell transplantation treatment for post-transplant relapse in myeloid hematologic malignancies.","authors":"Haixiao Zhang, Weijie Cao, Jia Liu, Ping Zhang, Wenwen Guo, Caidong Hu, Bo Nie, Qianwen Hu, Hongye Gao, Zhongxing Jiang, Guifang Ouyang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Mingxia Shi, Ting Yang, Fuxu Wang, Xi Zhang, Erlie Jiang","doi":"10.1097/CM9.0000000000004303","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004303","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149148244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction of maternal PM2.5 exposure and psychosocial state on newborn macrosomia: A nationwide population-based study. 母亲PM2.5暴露与心理社会状态对新生儿巨大儿的相互作用:一项基于全国人群的研究
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-10 DOI: 10.1097/CM9.0000000000004256
Jiaqi Qiang, Yunyun Luo, Yuelun Zhang, Zhibo Zhou, Xiaoyuan Guo, Yiling He, Hanze Du, Hongbo Yang, Huijuan Zhu, Shi Chen, Hui Pan
{"title":"Interaction of maternal PM2.5 exposure and psychosocial state on newborn macrosomia: A nationwide population-based study.","authors":"Jiaqi Qiang, Yunyun Luo, Yuelun Zhang, Zhibo Zhou, Xiaoyuan Guo, Yiling He, Hanze Du, Hongbo Yang, Huijuan Zhu, Shi Chen, Hui Pan","doi":"10.1097/CM9.0000000000004256","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004256","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron imbalance and colorectal cancer risk: Genetic and dietary influence. 铁失衡与结直肠癌风险:遗传和饮食影响。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-10 DOI: 10.1097/CM9.0000000000004159
Denise Goh, Dongke Xu, Joe Yeong
{"title":"Iron imbalance and colorectal cancer risk: Genetic and dietary influence.","authors":"Denise Goh, Dongke Xu, Joe Yeong","doi":"10.1097/CM9.0000000000004159","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004159","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A phase 2 study of venetoclax plus azacitidine as induction therapy in fit middle-aged patients with newly diagnosed acute myeloid leukemia. venetoclax联合阿扎胞苷作为诱导治疗适合新诊断的中年急性髓性白血病的2期研究。
IF 9.1 3区 医学
Chinese Medical Journal Pub Date : 2026-10-10 DOI: 10.1097/CM9.0000000000004325
Rui Huang, Xiaonan Lin, Yaling Zheng, Yuming Zhang, Honghua He, Yongzhong Su, Feiheng Chen, Shaoze Lin, Caixia Wang, Zhenqian Huang, Yaya Wang, Jihao Zhou, Lina Hu, Xiong Zhang, Ying Dong, Yuexiong Liang, Pengcheng Huang, Shuyi Mo, Jinxiong Huang, Xiaotao Wang, Fang Jiang, Xuekui Gu, Zenghui Liu, Ying Zhao, Xiaoli Xu, Ming Wu, Xuan Zhou, Zhao Liang, Sanfang Tu, Chunyan Yue, Shaojie Wu, Chaoyang Song, Yanjie He, Yuhua Li
{"title":"A phase 2 study of venetoclax plus azacitidine as induction therapy in fit middle-aged patients with newly diagnosed acute myeloid leukemia.","authors":"Rui Huang, Xiaonan Lin, Yaling Zheng, Yuming Zhang, Honghua He, Yongzhong Su, Feiheng Chen, Shaoze Lin, Caixia Wang, Zhenqian Huang, Yaya Wang, Jihao Zhou, Lina Hu, Xiong Zhang, Ying Dong, Yuexiong Liang, Pengcheng Huang, Shuyi Mo, Jinxiong Huang, Xiaotao Wang, Fang Jiang, Xuekui Gu, Zenghui Liu, Ying Zhao, Xiaoli Xu, Ming Wu, Xuan Zhou, Zhao Liang, Sanfang Tu, Chunyan Yue, Shaojie Wu, Chaoyang Song, Yanjie He, Yuhua Li","doi":"10.1097/CM9.0000000000004325","DOIUrl":"https://doi.org/10.1097/CM9.0000000000004325","url":null,"abstract":"","PeriodicalId":10183,"journal":{"name":"Chinese Medical Journal","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书